|
Deconstructing interactions between diet, microbiome, and immunity to gain mechanistic insight into health and disease |
1K99AI159227-01A1 |
|
NIAID |
2022 |
|
Metabolic regulators of Treg/Th17 balance in CNS autoimmunity |
1R01AI169075-01A1 |
|
NIAID |
2022 |
|
Alu dsRNAs as adjuvants for influenza vaccines |
1R21AI164107-01A1 |
|
NIAID |
2022 |
|
Allograft inflammatory factor-1 and immune tolerance |
1R21AI171739-01 |
|
NIAID |
2022 |
|
B cell-targeted CAR-T treatment of CNS Autoimmunity |
1R21AI171994-01 |
|
NIAID |
2022 |
|
Human T cell Lymphotropic Virus Vaccine development |
1R41AI165061-01A1 |
|
NIAID |
2022 |
|
Novel immunotherapy against MOG antibody disease |
1R43AI172705-01 |
|
NIAID |
2022 |
|
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy |
3R01AI141526-04S1 |
|
NIAID |
2022 |
|
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity |
5DP2AI164306-02 |
|
NIAID |
2022 |
|
Altered innate leukocyte programming dynamics in sepsis |
5R01AI136386-05 |
|
NIAID |
2022 |